Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice. (6th November 2014) - Johnson, Christopher B; Riesenberg, Brian; Neitzke, Dan; Jeng, Emily K; Marcus, Warren D; Cole, David; Wong, Hing C; Rubinstein, Mark P